查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386122

水痘疫苗市場報告：2030 年趨勢、預測與競爭分析

Chickenpox Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

水痘疫苗趨勢和預測

預計到 2030 年，全球水痘疫苗市場將達到 46 億美元，2024 年至 2030 年複合年成長率為 5.8%。該市場的主要促進因素是世界各地免疫計劃的增加、公眾對水痘疫苗使用的認知的提高以及政府對免疫計劃的貢獻的增加。由於醫院和診所市場的商機，全球水痘疫苗市場的未來前景看好。

水痘疫苗市場洞察

Lucintel 預測，帶狀皰疹在預測期內將經歷最高的成長。

預計在預測期內醫院市場將出現高速成長。

由於完善的疫苗接種計劃以及人口成長對疫苗接種率的需求不斷增加，北美仍然是最大的地區。

市場規模/估計：以金額的水痘疫苗市場規模估計（10 億美元）。

趨勢和預測分析：各個區隔市場和地區的市場趨勢（2018-2023）和預測（2024-2030）。

依區隔市場分析：依產品類型、應用、最終用途和地區估算水痘疫苗的市場規模（以金額）。

區域分析：北美、歐洲、亞太地區和世界其他地區的水痘疫苗市場區隔。

成長機會：依產品類型、應用、最終用途和地區對水痘疫苗市場進行成長機會分析。

策略分析：水痘疫苗市場併購、新產品開發、競爭形勢等。

基於波特五力模型的產業競爭實力分析。

本報告回答了 11 個關鍵問題：

  • Q.1. 區隔市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個區隔市場將以更快的速度成長？為什麼？
  • Q.3.哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要課題和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去五年發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章執行摘要

第2章全球水痘疫苗市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與課題

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球水痘疫苗市場趨勢（2018-2023）與預測（2024-2030）
  • 依產品類型分類的全球水痘疫苗市場
    • 單價水痘疫苗
    • 水痘聯合疫苗
  • 全球水痘疫苗市場依應用
    • 腮腺炎
    • 麻疹
    • 德國麻疹
    • 水痘疫苗接種
    • 帶狀皰疹
    • 免疫
  • 全球水痘疫苗市場（依最終用途）
    • 醫院
    • 診所
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球水痘疫苗市場區域分佈
  • 北美水痘疫苗市場
  • 歐洲水痘疫苗市場
  • 亞太水痘疫苗市場
  • 其他地區水痘疫苗市場

第5章競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 依產品類型分類的全球水痘疫苗市場成長機會
    • 全球水痘疫苗市場成長機會（依應用）
    • 全球水痘疫苗市場成長機會（依最終用途）
    • 全球水痘疫苗市場成長機會（依地區）
  • 全球水痘疫苗市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 全球水痘疫苗市場產能擴張
    • 全球水痘疫苗市場的合併、收購與合資企業
    • 認證和許可

第7章主要企業概況

  • Bio-Med
  • GlaxoSmithKline
  • Emcure Pharmaceuticals
  • Novo Medi Services
  • Sanofi
  • Takeda Pharmaceutical
  • Changchun BCHT Biotechnology
  • Green Cross Holdings
  • Merck
  • Mitsubishi Chemical Holdings
簡介目錄

Chickenpox Vaccine Trends and Forecast

The future of the global chickenpox vaccine market looks promising with opportunities in the hospital and clinic markets. The global chickenpox vaccine market is expected to reach an estimated $4.6 billion by 2030 with a CAGR of 5.8% from 2024 to 2030. The major drivers for this market are increasing number of vaccination programs throughout the world, rising public awareness of the use of chickenpox vaccines, and growing government contribution in immunization programs.

A more than 150-page report is developed to help in your business decisions.

Chickenpox Vaccine by Segment

The study includes a forecast for the global chickenpox vaccine by product type, application, end use, and region.

Chickenpox Vaccine Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Monovalent Varicella Vaccine
  • Combination Varicella Vaccine

Chickenpox Vaccine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Mumps
  • Measles
  • Rubella
  • Varicella Immunization
  • Herpes Zoster
  • Immunization
  • Chickenpox Vaccination

Chickenpox Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Clinics
  • Others

Chickenpox Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Chickenpox Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies chickenpox vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the chickenpox vaccine companies profiled in this report include-

  • Bio-Med
  • GlaxoSmithKline
  • Emcure Pharmaceuticals
  • Novo Medi Services
  • Sanofi
  • Takeda Pharmaceutical
  • Changchun BCHT Biotechnology
  • Green Cross Holdings
  • Merck
  • Mitsubishi Chemical Holdings

Chickenpox Vaccine Market Insights

Lucintel forecasts that herpes zoster is expected to witness highest growth over the forecast period.

Within this market, hospital is expected to witness higher growth over the forecast period.

North America will remain the largest region due to presence of well-established vaccination program and growing demand for vaccine coverage rate with expanding population in the region.

Features of the Global Chickenpox Vaccine Market

Market Size Estimates: Chickenpox vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Chickenpox vaccine market size by product type, application, end use, and region in terms of value ($B).

Regional Analysis: Chickenpox vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, applications, end uses, and regions for the chickenpox vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the chickenpox vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the chickenpox vaccine market size?

Answer: The global chickenpox vaccine market is expected to reach an estimated $4.6 billion by 2030.

Q.2 What is the growth forecast for chickenpox vaccine market?

Answer: The global chickenpox vaccine market is expected to grow with a CAGR of 5.8% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the chickenpox vaccine market?

Answer: The major drivers for this market are increasing number of vaccination programs throughout the world, rising public awareness of the use of chickenpox vaccines and growing government contribution in immunization programs.

Q4. What are the major segments for chickenpox vaccine market?

Answer: The future of the chickenpox vaccine market looks promising with opportunities in the hospital and clinic markets.

Q5. Who are the key chickenpox vaccine market companies?

Answer: Some of the key chickenpox vaccine companies are as follows:

  • Bio-Med
  • GlaxoSmithKline
  • Emcure Pharmaceuticals
  • Novo Medi Services
  • Sanofi
  • Takeda Pharmaceutical
  • Changchun BCHT Biotechnology
  • Green Cross Holdings
  • Merck
  • Mitsubishi Chemical Holdings

Q6. Which chickenpox vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that herpes zoster is expected to witness highest growth over the forecast period.

Q7. In chickenpox vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to presence of well-established vaccination program and growing demand for vaccine coverage rate with expanding population in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the chickenpox vaccine market by product type (monovalent varicella vaccine and combination varicella vaccine), application (mumps, measles, rubella, varicella immunization, herpes zoster, immunization, and chickenpox vaccination), end use (hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Chickenpox Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Chickenpox Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Chickenpox Vaccine Market by Product Type
    • 3.3.1: Monovalent Varicella Vaccine
    • 3.3.2: Combination Varicella Vaccine
  • 3.4: Global Chickenpox Vaccine Market by Application
    • 3.4.1: Mumps
    • 3.4.2: Measles
    • 3.4.3: Rubella
    • 3.4.4: Varicella Immunization
    • 3.4.5: Herpes Zoster
    • 3.4.6: Immunization
    • 3.4.7: Chickenpox Vaccination
  • 3.5: Global Chickenpox Vaccine Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Clinics
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Chickenpox Vaccine Market by Region
  • 4.2: North American Chickenpox Vaccine Market
    • 4.2.1: North American Chickenpox Vaccine Market by Application: Mumps, Measles, Rubella, Varicella Immunization, Herpes Zoster, Immunization, and Chickenpox Vaccination
    • 4.2.2: North American Chickenpox Vaccine Market by End Use: Hospitals, Clinics, and Others
  • 4.3: European Chickenpox Vaccine Market
    • 4.3.1: European Chickenpox Vaccine Market by Application: Mumps, Measles, Rubella, Varicella Immunization, Herpes Zoster, Immunization, and Chickenpox Vaccination
    • 4.3.2: European Chickenpox Vaccine Market by End Use: Hospitals, Clinics, and Others
  • 4.4: APAC Chickenpox Vaccine Market
    • 4.4.1: APAC Chickenpox Vaccine Market by Application: Mumps, Measles, Rubella, Varicella Immunization, Herpes Zoster, Immunization, and Chickenpox Vaccination
    • 4.4.2: APAC Chickenpox Vaccine Market by End Use: Hospitals, Clinics, and Others
  • 4.5: ROW Chickenpox Vaccine Market
    • 4.5.1: ROW Chickenpox Vaccine Market by Application: Mumps, Measles, Rubella, Varicella Immunization, Herpes Zoster, Immunization, and Chickenpox Vaccination
    • 4.5.2: ROW Chickenpox Vaccine Market by End Use: Hospitals, Clinics, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Chickenpox Vaccine Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Chickenpox Vaccine Market by Application
    • 6.1.3: Growth Opportunities for the Global Chickenpox Vaccine Market by End Use
    • 6.1.4: Growth Opportunities for the Global Chickenpox Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Chickenpox Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Chickenpox Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Chickenpox Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Bio-Med
  • 7.2: GlaxoSmithKline
  • 7.3: Emcure Pharmaceuticals
  • 7.4: Novo Medi Services
  • 7.5: Sanofi
  • 7.6: Takeda Pharmaceutical
  • 7.7: Changchun BCHT Biotechnology
  • 7.8: Green Cross Holdings
  • 7.9: Merck
  • 7.10: Mitsubishi Chemical Holdings